May 4th, 2015
For more than 200 years physicians have been trying to figure out how and when to use digoxin. Although it has a narrow therapeutic window and potentially dangerous interactions with other drugs, it is endorsed by current guidelines and widely given to patients with heart failure (HF) and atrial fibrillation (AF). However, there have been no […]
April 9th, 2015
Manesh R. Patel discusses his research group’s retrospective analysis of data on digoxin use among patients with atrial fibrillation in the ROCKET AF trial.
August 11th, 2014
Mintu P. Turakhia discusses his observational study of digoxin use and mortality risk in patients with atrial fibrillation, using data from the TREAT-AF study.
August 11th, 2014
Digoxin is one of the oldest drugs in the cardiovascular arsenal, derived from the foxglove plant and first described in the 18th century by William Withering. It is frequently used in patients with heart failure (HF) and with atrial fibrillation (AF). The few trials supporting its use were performed in HF patients before newer treatments […]
October 17th, 2013
James Freeman discusses his research group’s evaluation of the contemporary effectiveness and safety of digoxin therapy among adults with newly diagnosed systolic heart failure.
September 24th, 2013
Digoxin is one of the oldest medicines in the cardiovascular arsenal. When William Withering identified it as the active ingredient in the foxglove plant more than 200 years ago, he was only codifying a longstanding folk remedy for heart failure, or “dropsy” as it was known then. Digoxin fully entered the modern era with the publication […]
March 21st, 2013
The evidence is just not compelling that this this drug would reduce hospital readmissions